Repligen (RGEN) Restructuring Costs (2012 - 2026)

Repligen's (RGEN) quarterly Restructuring Costs came in at $1.5 million in Q1 2026, down 24.18% year-on-year from $2.0 million in Q1 2025, and down 24.18% on a QoQ basis from $2.0 million in Q1 2025.

Repligen (RGEN) Restructuring Costs (2012 - 2026) Analysis & Trends

Repligen (RGEN) has 5 years of Restructuring Costs data on file, last reported at $1.5 million in Q1 2026.

  • On a quarterly basis, Restructuring Costs fell 24.18% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 37.46% increase from a year earlier, with the FY2014 full-year figure at $1.9 million, up 2032.89% from the prior year.
  • Restructuring Costs for Q1 2026 stood at $1.5 million, down from $2.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for RGEN reached as high as $2.0 million in Q1 2025 and fell as low as $1.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Repligen 7.75 Bn 6.77 Bn 108.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.50 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2014 1.95 Mn
Sep 30, 2014 10,000.00
Jun 30, 2014 18,000.00
Mar 31, 2014 98,000.00
Dec 31, 2013 45,000.00
Sep 30, 2013 65,000.00
Jun 30, 2013 35,000.00
Mar 31, 2013 -54,000.00
Dec 31, 2012 267,000.00
Sep 30, 2012 344,000.00